Most people don't enjoy getting shots for treatments or vaccines ... oRNA Therapeutics and Moderna, biotechnology companies ...

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...

Most people don’t enjoy getting shots for treatments or vaccines. So ... Chemical Society reports steps toward making inhalable mRNA medicines a possibility. Researchers outline their improved ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

The vaccine uses the same lipid nanoparticles (LNPs) as the Moderna COVID-19 vaccine. About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA ...

The government’s deal with Maryland-based Novavax requires the company to obtain regulatory approval for a vaccine using ingredients made at the Biologics Manufacturing Centre (BMC) in Montreal before ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

is pleased to announce that its ongoing research effort to develop lipid-polymer delivery formulations for thermostable mRNA vaccines has been funded by the Bill & Melinda Gates Foundation under a ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...